Who owns Roivant Sciences Ltd. (ROIV)? Elite investor 13F holders
7 tracked elite investors reported holding Roivant Sciences Ltd as of 2026-09-30, including Rubric Capital, Viking Global Investors, D.E. Shaw, Maverick Capital, Greenlight Capital. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rubric Capital | ROIVANT SCIENCES LTD | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 273599333.00 USD | 7481524.000000 | Shares | add | Original filing |
| Viking Global Investors | ROIVANT SCIENCES LTD | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 247115412.00 USD | 6757326.000000 | Shares | add | Original filing |
| D.E. Shaw | ROIVANT SCIENCES LTD | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 92940095.00 USD | 2541430.000000 | Shares | reduce | Original filing |
| Maverick Capital | ROIVANT SCIENCES LTD | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 84396209.00 USD | 2307799.000000 | Shares | reduce | Original filing |
| Greenlight Capital | ROIVANT SCIENCES LTD | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 41387988.00 USD | 1131747.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | ROIVANT SCIENCES LTD | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 55744017.00 USD | 1524310.000000 | Shares | add | Original filing |
| Polen Capital Management | ROIVANT SCIENCES LTD | SHARE | 2026-09-30 | 2026-11-13 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Ancora Advisors / Ancora Holdings | ROIVANT SCIENCES LTD | SHARE | 2026-09-30 | 2026-11-17 00:00:00 | 914.00 USD | 25.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.